Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
International Journal of Psychiatry in Medicine|January 1, 1985
L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental studyS R Kay, L A OplerNeuropsychobiology|January 1, 1979
Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological modelM M Singh, S R KayComprehensive Psychiatry|January 1, 1991
Stability of psychopathology dimensions in chronic schizophrenia: response to clozapine treatmentS R Kay, J P LindenmayerNeuropsychobiology|January 1, 1989
Alpha-2-adrenoreceptor binding as a possible vulnerability marker for affective disordersJ Mendlewicz, D Hirsch, S Sevy, et al.The American Journal of Psychiatry|August 1, 1989
Defense mechanisms in risk of suicide and risk of violenceA Apter, R Plutchik, S Sevy, et al.Lancet (London, England)|May 30, 1987
Polymorphic DNA marker on X chromosome and manic depressionJ Mendlewicz, P Simon, S Sevy, et al.Psychiatry Research|May 1, 1990
Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster?A Apter, H M van Praag, R Plutchik, et al.The British Journal of Psychiatry : the Journal of Mental Science|October 1, 1986
Significance of positive and negative syndromes in chronic schizophreniaS R Kay, L A Opler, A FiszbeinSchizophrenia Bulletin|January 1, 1987
The positive and negative syndrome scale (PANSS) for schizophreniaS R Kay, A Fiszbein, L A OplerThe International Journal of Neuroscience|April 1, 1991
Atrophy of the cerebellar vermis: relevance to the symptoms of schizophreniaR Sandyk, S R Kay, A E MerriamPageof 10